Copy
See below for a daily digest of the latest Huntington's Disease news!

Huntington's Disease News Weekly Digest

Contents:

Phase 1/2 Trial of SBT-20 In Early-stage Huntington’s Begins in Holland

May 04, 2017 08:43 am | Joana Fernandes, PhD

 

Huntington's trial startsStealth BioTherapeutics has started a Phase 1/2 clinical trial to investigate the safety and effectiveness of SBT-20 in patients with early-stage Huntington’s disease in the Netherlands. SBT-20 was designed to restore the proper activity of mitochondria, the cell’s powerhouses, in Huntington’s patients. Mitochondria organelles become faulty as the disease progresses. “Huntington’s disease is a fatal genetic […]

The post Phase 1/2 Trial of SBT-20 In Early-stage Huntington’s Begins in Holland appeared first on Huntington's Disease News.

Read More
share on Twitter Like Phase 1/2 Trial of SBT-20 In Early-stage Huntington’s Begins in Holland on Facebook

Recent Posts

Treatment with VX15 May Protect Brain in Early Phase Huntington’s, Data Shows
Clinical Trial Results Suggest Teva’s Pridopidine May Delay Functional Decline in Huntington’s Patients
Pope Francis to Meet in Vatican with Large Contingent from Global Huntington’s Community
Results of Probiodrug AG Mouse Study to be Presented at HD Therapeutics Conference
Early Huntington’s Patients More Impulsive, but Show Normal Risk Behaviors

Copyright © 2017 BioNews Services, LLC, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences